Biomarkers of space radiation risk

Radiation Research

Volumn 164, Issue 4 II, 2005, Pages 467-473

  Durante, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLOOD TOXICITY; CANCER RISK; CHROMOSOME ABERRATION; CONFERENCE PAPER; COSMIC RADIATION; COSMONAUT; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DAMAGE; DOSIMETRY; GAMMA RADIATION; HUMAN; IONIZING RADIATION; LYMPHOCYTE; MEASUREMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RISK ASSESSMENT; SPACE; TIME SERIES ANALYSIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CHROMOSOME ABERRATIONS; COSMIC RADIATION; LUNG NEOPLASMS; LYMPHOCYTES; RADIOMETRY; RISK; SPACE FLIGHT; TIME FACTORS;

EID: 25444497977     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3359.1     Document Type: Conference Paper

References (55)

1. A. L. Brooks, Biomarkers of exposure, sensitivity and disease. Int. J. Radiat. Biol. 75, 1481-1503 (1999).
2. A. L. Brooks, Biomarkers of exposure and dose: state of the art. Radiat. Prot. Dosim. 97, 39-46 (2001).
3. B. V. Worgul, L. Smilenov, D. J. Brenner, A. Junk, W. Zhou and E. J. Hall, ATM heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc. Natl. Acad. Sci. USA 99, 9836-9839 (2002).
4. S. Bonassi and W. W. Au, Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511, 73-86 (2002).
5. G. Horneck, Biological monitoring of radiation exposure. Adv. Space Res. 22, 1631-1641 (1998).
6. ICRU, Retrospective Assessment of Exposures to Ionizing Radiation. Report 68, International Commission on Radiation Units and Measurements, Bethesda, MD, 2002.
7. F. A. Cucinotta, W. Schimmerling, J. W. Wilson, L. E. Peterson, G. D. Badhwar, P. B. Saganti and J. F. Dicello, Space radiation cancer risks and uncertainties for Mars missions. Radiat. Res. 156, 682-688 (2001).
8. NASA, Strategic Program Plan for Space Radiation Health Research. NASA, Washington, DC, 1998. [available online at http://srhp.jsc.nasa.gov/docs/ StrategicPlans/StrategicPlan98.pdf]
9. NCRR Radiation Protection Guidance for Activities in Low-Earth Orbit. Report no. 132, National Council on Radiation Protection and Measurements, Bethesda, MD, 2000.
10. M. Durante, Potential applications of biomarkers of radiation exposure in nuclear terrorism events. Phys. Med. 19, 191-212 (2003).
11. C. L. Greenstock and A. Trivedi, Biological and biophysical techniques to assess radiation exposure: a perspective. Prog. Biophys. Mol. Biol. 61, 81-130 (1994).
12. S. A. Amundson, M. Bittner, P. Meltzer, J. Trent and A. J. Fornace, Jr., Biological indicators for the identification of ionizing radiation exposure in humans. Exp. Rev. Mol. Diagn. 1, 211-219 (2001).
13. W. F. Blakely, P. G. Prasanna, M. B. Grace and A. C. Miller, Radiation exposure assessment using cytological and molecular biomarkers. Radiat. Prot. Dosim. 97, 17-23 (2001).
14. E. H. Haskell, R. B. Hayes, G. H. Kenner, S. V. Sholom and V. I. Chumak, Electron paramagnetic resonance techniques and space biodosimetry. Radiat. Res. 148 (Suppl.), S51-S59 (1997).
15. IAEA, Cytogenetic Analysis for Radiation Dose Assessment. Technical report no. 405, International Atomic Energy Agency, Vienna, 2001.
16. I. Testard, M. Ricoul, F. Hoffschir, A. Fluty-Herard, B. Dutrillaux, B. S. Fedorenko, V. Gerassimenko and L. Sabatier, Radiation-induced chromosome damage in astronauts' lymphocytes. Int. J. Radiat. Biol. 70, 403-411 (1996).
17. G. Obe, I. Johannes, C. Johannes, K. Hallman, G. Reitz and R. Facius, Chromosomal aberrations in blood lymphocytes of astronauts after long-term space flights. Int. J. Radiat. Biol. 72, 727-734 (1997).
18. T. C. Yang, K. George, A. S. Johnson, M. Durante and B. S. Fedorenko, Biodosimetry results from space flight Mir-18. Radiat. Res. 148 (Suppl.), S17-S23 (1997).
19. K. George, M. Durante, H. Wu, V. Willingham, G. Badhwar and F. A. Cucinotta, Chromosome aberrations in the blood lymphocytes of astronauts after space flight. Radiat. Res. 156, 731-738 (2001).
20. K. George, H. Wu, V. Willingham and F. A. Cucinotta, The effect of space radiation on the induction of chromosome damage. Phys. Med. 17, S222-S225 (2001).
21. K. George, M. Durante, V. Willingham and F. A. Cucinotta, Chromosome aberrations of clonal origin are present in astronauts' blood lymphocytes. Cytogenet. Genome Res. 104, 245-251 (2004).
22. B. S. Fedorenko, S. Druzhinin, L. Yudaeva, V. Petrov, T. Akatov, G. Snigiryova, N. Novitskaya, V. Shevchenko and A. Rubanovich, Cytogenetic studies of blood lymphocytes from cosmonauts after long-term space flights on Mir station. Adv. Space Res. 27, 355-359 (2001).
23. M. Durante, G. Snigiryova, E. Akaeva, A. Bogomazova, S. Druzhinin, B. Fedorenko, O. Greco, N. Novitskaya, A. Rubanovich and G. Obe, Chromosome aberration dosimetry in cosmonauts after single or multiple space flights. Cytogenet. Genome Res. 103, 40-46 (2003).
24. O. Greco, M. Durante, G. Gialanella, G. Grossi, M. Pugliese, P. Scampoli, G. Snigiryova and G. Obe, Biological dosimetry in Russian and Italian astronauts. Adv. Space Res. 31, 1495-1503 (2003).
25. J. B. Cologne, D. J. Pawel and D. L. Preston, Statistical issues in biological radiation dosimetry for risk assessment using stable chromosome aberrations. Health Phys. 75, 518-529 (1998).
26. F. A. Cucinotta, J. W. Wilson, J. R. Williams and J. F. Dicello, Analysis of MIR-18 results for physical and biological dosimetry: Radiation shielding effectiveness in LEO. Radiat. Meas. 32, 181-191 (2000).
27. F. A. Cucinotta, Once we know all the radiobiology we need to know, how can we use it to predict space radiation risks and achieve fame and fortune? Phys. Med. 17 (Suppl.), S5-S12 (2001).
28. O. M. Sieber, K. Heinimann and I. P. Tomlinson, Genomic instability - the engine of tumorigenesis? Nat. Rev. Cancer 3, 701-708 (2003).
29. L. Hagmar, S. Bonassi, U. Strömberg, A. Brøgger, L. Knudsen, H. Norppa and C. Reuterwall, Chromosomal aberrations in lymphocytes predict human cancer - a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58, 4117-4121 (1998).
30. S. Bonassi, L. Hagmar, U. Strömberg, A. Huici Montagud, H. Tinnerberg, A. Forni, P. Heikkilä, S. Wanders, P. Wilhardt and H. Norppa, for the European Study Group on Cytogenetic Biomarkers and Health (ESCH), Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60, 1619-1625 (2000).
31. L. Hagmar, U. Strömberg, S. Bonassi, I-L. Hansteen, L. E. Knudsen, C. Lindholm and H. Norppa, Impact of types of lymphocyte chromosomal aberrations on human cancer risk: Results from Nordic and Italian cohorts. Cancer Res. 64, 2258-2263 (2004).
32. Z. Smerhovsky, K. Landa, P. Rossner, M. Brabec, Z. Zudova, N. Hola, Z. Pokorna, J. Mareckova and D. Hurychova, Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ. Health Perspect. 109, 41-45 (2001).
33. S. H. Liou, J. C. Lung, Y. H. Chen, T. Yang, L. L. Hsieh, C. J. Chen and T. N. Wu, Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res. 59, 1481-1484 (1999).
34. S. Bonassi, Combining environmental exposure and genetic effect measurements in health outcome assessment. Mutat. Res. 428, 177-185 (1999).
35. M. Durante, S. Bonassi, K. George and F. A. Cucinotta, Risk estimation based on chromosomal aberrations induced by radiation. Radiat. Res. 156, 662-667 (2001).
36. D. A. Pierce and D. L. Preston, Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 154, 178-186 (2000).
37. G. D. Badhwar, W. Atwell, G. Reitz, R. Beaujean and W. Heinrich, Radiation measurements on the Mir Orbital Station. Radiat. Meas. 35, 393-422 (2002).
38. G. Obe, R. Facius, G. Reitz, I. Johannes and C. Johannes, Manned missions to Mars and chromosome damage. Int. J. Radiat. Biol. 75, 429-433 (1999).
39. ESA, HUMEX: Study on Survivability and Adaptation of Humans to Long-Duration Exploratory Missions. ESA SP-1264, ESTEC, Nordwijk, 2003. [available online at www.estec.esa.nl/ecls/melissa/attachments/humex/tn3.pdf]
40. 60Co γ-rays at body temperature. Int. J. Radiat. Biol. 75, 435-439 (1999).
41. C. Lindholm, H. Romm, G. Stephan, E. Schmid, J. Moquet and A. A. Edwards, Intercomparison of translocation and dicentric frequencies between laboratories in a follow-up of the radiological accident in Estonia. Int. J. Radiat. Biol. 78, 883-890 (2002).
42. M. L. Camparoto, A. T. Ramalho, A. T. Natarajan, M. P. Curado and E. T. Sakamoto-Hojo, Translocation analysis by the FISH-painting method for retrospective dose reconstruction in individuals exposed to ionizing radiation 10 years after exposure. Mutat. Res. 530, 1-7 (2003).
43. M. Bauchinger, H. Braselmann, J. R. Savage, A. T. Natarajan, G. I. Terzoudi, G. E. Pantelias, F. Darroudi, M. Figgitt, C. S. Griffin and G. Snigiryova, Collaborative exercise on the use of FISH chromosome painting for retrospective biodosimetry of Mayak nuclear-industrial personnel. Int. J. Radiat. Biol. 77, 259-267 (2001).
44. L. E. Burak, Y. Kodama, M. Nakano, K. Ohtaki, M. Itoh, N. D. Okladnikova, E. K. Vasilenko, J. B. Cologne and N. Nakamura, FISH examination of lymphocytes from Mayak workers for assessment of translocation induction rate under chronic radiation exposures. Int. J. Radiat. Biol. 77, 901-908 (2001).
45. G. Sonnenfeld, J. S. Butel and W. T. Shearer, Effects of the space flight environment on the immune system. Rev. Environ. Health 18, 1-17 (2003).
46. K. George, V. Willingham and F. A. Cucinotta, Stability of chromosome aberrations in blood lymphocytes of astronauts, measured after space flight by FISH-chromosome painting. Radiat. Res. 164, 474-480 (2005).
47. D. L. Preston, D. A. Pierce, Y. Shimizu, E. Ron and K. Mabuchi, Dose response and temporal patters of radiation-associated solid cancer risks. Health Phys. 85, 43-46 (2003).
48. P. B. Bach, M. W. Kattan, M. D. Thornquist, M. G. Kris, R. C. Tate, M. J. Barnett, L. J. Hsieh and C. B. Begg, Variations in lung cancer risk among smokers. J. Natl. Cancer Inst. 95, 470-478 (2003).
49. Y. Y. Tsai, K. A. McGlynn, Y. Hu, A. B. Cassidy, J. Arnold, P. F. Engstrom and K. H. Buetow, Genetic susceptibility and dietary patterns in lung cancer. Lung Cancer 41, 269-281 (2003).
50. M. T. Halpern, B. W. Gillespie and K. E. Warner, Patterns of absolute risk of lung cancer mortality in former smokers. J. Natl. Cancer Inst. 85, 457-464 (1993).
51. J. O. Ebbert, P. Yang, C. M. Vachon, R. A. Vierkant, J. R. Cerhan, A. R. Folsom and T. A. Sellers, Lung cancer risk reduction after smoking cessation: Observations from a prospective cohort of women. J. Clin. Oncol. 21, 921-926 (2003).
52. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
53. D. A. Pierce and M. Vaeth, Age-time patterns of cancer to be anticipated from exposure to general mutagens. Biostatistics 4, 231-248 (2003).
54. R. J. Albertini, Validated biomarker responses influence medical surveillance of individuals exposed to genotoxic agents. Radiat. Prot. Dosim. 97, 47-54 (2001).
55. M. Durante, K. George, G. Gialanella, G. Grossi, C. La Tessa, L. Manti, J. Miller, M. Pugliese, P. Scampoli and F. A. Cucinotta, Cytogenetic effects of high-energy iron ions: dependence on shielding thickness and material. Radiat. Res. 164, 571-576 (2005).